In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.

MLA

Ding, Ning, et al. “In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.” Molecular Imaging & Biology, vol. 18, no. 6, Dec. 2016, pp. 870–76. EBSCOhost, https://doi.org/10.1007/s11307-016-0977-2.

APA

Ding, N., Sano, K., Kanazaki, K., Ohashi, M., Deguchi, J., Kanada, Y., Ono, M., & Saji, H. (2016). In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody. Molecular Imaging & Biology, 18(6), 870–876. https://doi.org/10.1007/s11307-016-0977-2

Chicago

Ding, Ning, Kohei Sano, Kengo Kanazaki, Manami Ohashi, Jun Deguchi, Yuko Kanada, Masahiro Ono, and Hideo Saji. 2016. “In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.” Molecular Imaging & Biology 18 (6): 870–76. doi:10.1007/s11307-016-0977-2.